086450.KQ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 02:30):

Stats
Today's Volume	71 509.00
Average Volume	204 535
Market Cap	676.87B
EPS	KRW0 ( 2024-03-14 )
Next earnings date	( KRW0 ) 2024-05-12
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW10.48 (0.07%)

Volume Correlation

Long: 0.03 (neutral)

Short: -0.62 (weak negative)

Signal:(45.489) Neutral

DongKook Pharmaceutical Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

DongKook Pharmaceutical Correlation - Currency/Commodity

-0.84
( strong negative )

-0.89
( strong negative )

-0.75
( moderate negative )

-0.82
( strong negative )

0.30
( neutral )

-0.82
( strong negative )

DongKook Pharmaceutical Financials

Annual	2023
Revenue:	KRW730.99B
Gross Profit:	KRW405.04B (55.41 %)
EPS:	KRW1 073.13

Q4	2023
Revenue:	KRW187.88B
Gross Profit:	KRW103.13B (54.89 %)
EPS:	KRW206.21

Q3	2023
Revenue:	KRW176.44B
Gross Profit:	KRW98.76B (55.98 %)
EPS:	KRW276.02

Q2	2023
Revenue:	KRW185.88B
Gross Profit:	KRW102.81B (55.31 %)
EPS:	KRW226.15

Financial Reports:

No articles found.

DongKook Pharmaceutical

DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.